CoreWeave’s $9 Billion Core Scientific Bid Faces Shareholder Revolt as CEO Calls Deal “Nice to Have”

Deal Dynamics Shift as Major Investors Push Back

CoreWeave CEO Michael Intrator has significantly downplayed the importance of his company‘s proposed $9 billion acquisition of Bitcoin miner Core Scientific, characterizing the deal as a “nice to have” rather than essential to CoreWeave’s strategy. This comes as shareholder opposition to the all-stock transaction intensifies, with a crucial vote scheduled for October 30 that could determine the deal’s fate.

Deal Dynamics Shift as Major Investors Push Back
Proxy Advisor Adds Fuel to Shareholder Rebellion
Major Shareholder Voices Strong Opposition
CoreWeave’s Aggressive Acquisition Strategy
Market Implications and Future Prospects

The acquisition proposal, announced in July, immediately triggered a negative market reaction with Core Scientific’s stock price dropping nearly 18%. Since then, the stock has recovered and continued climbing, suggesting investors believe the company is worth substantially more than CoreWeave’s offer.

Proxy Advisor Adds Fuel to Shareholder Rebellion

Institutional Shareholder Services (ISS), a highly influential proxy advisory firm, dealt a significant blow to the deal on Monday by recommending that shareholders vote against the acquisition. ISS noted that Core Scientific’s rising share price indicates market consensus that the company is undervalued in the proposed transaction.

Intrator expressed disappointment with the ISS recommendation but maintained that the deal remains “in the long-term interest of Core Scientific shareholders.” Despite mounting opposition, the CoreWeave CEO confirmed the company will not increase its offer price, stating, “Everything has a value, and the number we put out is the value we’re willing to pay for them under all circumstances.”

Major Shareholder Voices Strong Opposition

Two Seas Capital, a significant Core Scientific shareholder, has publicly condemned the proposed acquisition as “underwhelming.” In an October 17 letter to shareholders, the investment firm declared, “We see no reason why Core Scientific shareholders should accept such an underwhelming deal. Based on recent trading data, we see little evidence that they will.”

The opposition from both institutional advisors and major shareholders creates substantial hurdles for CoreWeave as it seeks approval for what would be one of its largest acquisitions to date.

CoreWeave’s Aggressive Acquisition Strategy

The proposed Core Scientific acquisition fits within CoreWeave’s broader pattern of aggressive expansion through strategic purchases. The AI cloud provider has been actively acquiring AI-focused companies throughout 2024, including notable purchases of OpenPipe, Weights & Biases, and Monolith.

CoreWeave has positioned itself as a key infrastructure provider in the artificial intelligence boom, building data centers and offering Nvidia-powered computing capacity to major hyperscalers like Microsoft. “We’ve been in acquisitive mode as we continue to build and extend the functionality of our company,” Intrator explained, highlighting the company’s growth-through-acquisition philosophy.

Market Implications and Future Prospects

The outcome of the October 30 shareholder vote could have significant implications for both companies and the broader AI infrastructure sector. A rejection would represent a rare setback for CoreWeave’s acquisition strategy and could force the company to pursue alternative growth paths., as detailed analysis

For Core Scientific shareholders, the decision represents a critical valuation judgment about whether to accept CoreWeave’s stock-based offer or maintain ownership in a company that appears to be gaining market confidence independently. The rising share price since the deal announcement suggests many investors believe the latter option holds greater potential value.

As the vote approaches, the “nice to have” characterization from CoreWeave’s CEO may further complicate an already challenging path to shareholder approval, potentially signaling to investors that CoreWeave lacks the urgency needed to justify accepting what many perceive as an inadequate offer.